Inclusion Criteria:
  -  Metastatic or locally advanced non-small cell lung cancer (stage III or IV)
  -  At least one measurable target according to RECIST criteria
  -  Identification of at least one molecular alteration in the tissue sample analyzed in the framework of patient management
  -  Performance Status 0 to 2
  -  Affiliated to a social security system
  -  Patient who can be followed under the protocol
  -  Patient agreed to participate in the study and gave his/her express consent
Exclusion Criteria:
  -  Minor
  -  Small cell or mixed bronchial cancer
  -  Radiotherapy (except radiotherapy for antalgic purposes) during the last 7 days
  -  Patient who has already started a first line of treatment
  -  Patient already included in an interventional research protocol that may have an impact on the results of the ELUCID study
  -  History of cancer (with the exception of non-melanoma skin, cervical cancer in situ, adequately treated) with sign of illness during the last 5 years
  -  Patient which, does present a substantial risk of recurrence.
  -  Major under guardianship, curators or deprived of liberty
  -  Pregnant or lactating woman, or of childbearing age without effective contraception
  -  Not affiliated to a social security system
  -  Inability to understand the protocol and / or to give express consent